A5114804316- Long-Term Effects of COVID-19
- COVID-19 and healthcare impacts
- COVID-19 Clinical Research Studies
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Fibromyalgia and Chronic Fatigue Syndrome Research
- Heart Rate Variability and Autonomic Control
- Management of metastatic bone disease
- SARS-CoV-2 and COVID-19 Research
- COVID-19 and Mental Health
- Cardiac Health and Mental Health
- Cancer Diagnosis and Treatment
- Pulmonary Hypertension Research and Treatments
- Bone health and treatments
Skåne University Hospital
2024
Lund University
2024
Amgen (United States)
2021-2022
Abstract Postural Orthostatic Tachycardia Syndrome (POTS) reflects an autonomic dysfunction, which can occur as a complication to COVID-19. Our aim was examine gastrointestinal symptoms and gut microbiota composition in patients with POTS post-acute COVID-19 syndrome (PACS), compared controls. ( n = 27), PACS 32) controls 39) delivered fecal samples completed 4-day food diary, irritable bowel syndrome-severity scoring system (IBS-SSS), visual analog scale for IBS (VAS-IBS). A total of 98 DNA...
Dysregulation of the complement system has been proposed as a pathophysiological mechanism for Post-acute sequelae SARS-CoV-2 (PASC). We analyzed activation markers C3bc, C3bBbP and TCC in 48 PASC patients, grouped into whether they had mild (n=38) or severe (n=10) acute infection, 80 control subjects. Although patients with infection trend towards more PASC, we could not find any significant differences between these controls. In conclusion, convincing evidence patients.
Objectives To examine the temporal patterns of patient characteristics, treatments used and outcomes associated with COVID-19 in patients who were hospitalised for disease between January 15 November 2020. Design Observational cohort study. Setting subset Optum deidentified electronic health records, including more than 1.8 million from across USA. Participants There 51 510 met definition, 37 617 laboratory positive 13 893 clinical cohort. Primary secondary outcome measures Incident acute...
Abstract PURPOSE Nearly 40% of patients with bone metastases from breast cancer experience a skeletal-related event (SRE) such as fracture, spinal cord compression, surgery, or radiation to bone, within 1 year diagnosis (1). Bone-targeting agents (BTAs) significantly reduce the risk SREs, but real-world data indicates that only 58% (Commercial) and 67% (Medicare) eligible metastatic receive treatment BTA (2, 3). We surveyed U.S. ascertain their awareness regarding health, describe source...